Free Trial
→ Your blueprint for crypto wealth (From Crypto 101 Media) (Ad) Free TXN Stock Alerts

Texas Instruments (TXN) Financials

Texas Instruments logo
$180.86 -0.20 (-0.11%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$180.62 -0.24 (-0.13%)
As of 08/1/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Texas Instruments

Annual Income Statements for Texas Instruments

This table shows Texas Instruments' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 2,944 3,551 3,649 5,538 4,986 5,568 7,736 8,710 6,477 4,775
Consolidated Net Income / (Loss)		 2,986 3,595 3,682 5,580 5,017 5,595 7,769 8,749 6,510 4,799
Net Income / (Loss) Continuing Operations		 2,986 3,595 3,682 5,580 5,017 5,595 7,769 8,749 6,510 4,799
Total Pre-Tax Income 		4,216 4,930 6,080 6,686 5,728 6,017 8,919 10,032 7,418 5,453
Total Operating Income		 4,322 4,855 6,083 6,713 5,723 5,894 8,960 10,140 7,331 5,465
Total Gross Profit		 7,575 8,257 9,614 10,277 9,164 9,269 12,376 13,771 11,019 9,094
Total Revenue		 13,000 13,370 14,961 15,784 14,383 14,461 18,344 20,028 17,519 15,641
Operating Revenue		 13,000 13,370 14,961 15,784 14,383 14,461 18,344 20,028 17,519 15,641
Total Cost of Revenue		 5,425 5,113 5,347 5,507 5,219 5,192 5,968 6,257 6,500 6,547
Operating Cost of Revenue		 5,425 5,113 5,347 5,507 5,219 5,192 5,968 6,257 6,500 6,547
Total Operating Expenses		 3,253 3,402 3,531 3,564 3,441 3,375 3,416 3,631 3,688 3,629
Selling, General & Admin Expense		 1,728 1,742 1,694 1,684 1,645 1,647 1,720 1,704 1,825 1,794
Research & Development Expense		 1,267 1,356 1,508 1,559 1,544 1,530 1,554 1,670 1,863 1,959
Restructuring Charge		 258 304 329 321 -36 - - 257 0.00 -124
Total Other Income / (Expense), net		 -106 75 -3.00 -27 5.00 123 -41 -108 87 -12
Interest Expense		 90 80 78 125 170 190 184 214 353 508
Other Income / (Expense), net		 -16 155 75 98 175 313 143 106 440 496
Income Tax Expense		 1,230 1,335 2,398 1,106 711 422 1,150 1,283 908 654
Preferred Stock Dividends Declared		 42 44 33 42 31 27 33 39 33 24
Basic Earnings per Share		 $2.86 $3.54 $3.68 $5.71 $5.33 $6.05 $8.38 $9.51 $7.13 $5.24
Weighted Average Basic Shares Outstanding		 1.03B 1.00B 991M 970M 936M 921M 923M 916M 908M 912M
Diluted Earnings per Share		 $2.82 $3.48 $3.61 $5.59 $5.24 $5.97 $8.26 $9.41 $7.07 $5.20
Weighted Average Diluted Shares Outstanding		 1.04B 1.02B 1.01B 990M 952M 933M 936M 926M 916M 919M
Weighted Average Basic & Diluted Shares Outstanding		 1.03B 1.00B 991.60M 969.90M 933.98M 920.24M 923.55M 906.21M 909.29M 910.33M
Cash Dividends to Common per Share		 $1.40 $1.64 $2.12 $2.63 $3.21 $3.72 $4.21 $4.69 $5.02 $5.26

Quarterly Income Statements for Texas Instruments

This table shows Texas Instruments' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 2,284 1,953 1,699 1,714 1,699 1,365 1,100 1,121 1,355 1,199 1,173
Consolidated Net Income / (Loss)		 2,295 1,962 1,708 1,722 1,709 1,371 1,105 1,127 1,362 1,205 1,179
Net Income / (Loss) Continuing Operations		 2,295 1,962 1,708 1,722 1,709 1,371 1,105 1,127 1,362 1,205 1,179
Total Pre-Tax Income 		2,658 2,167 1,946 2,002 1,922 1,548 1,293 1,247 1,554 1,359 1,276
Total Operating Income		 2,678 2,176 1,934 1,972 1,892 1,533 1,286 1,248 1,554 1,377 1,324
Total Gross Profit		 3,617 3,087 2,863 2,910 2,815 2,431 2,095 2,211 2,474 2,314 2,313
Total Revenue		 5,241 4,670 4,379 4,531 4,532 4,077 3,661 3,822 4,151 4,007 4,069
Operating Revenue		 5,241 4,670 4,379 4,531 4,532 4,077 3,661 3,822 4,151 4,007 4,069
Total Cost of Revenue		 1,624 1,583 1,516 1,621 1,717 1,646 1,566 1,611 1,677 1,693 1,756
Operating Cost of Revenue		 1,624 1,583 1,516 1,621 1,717 1,646 1,566 1,611 1,677 1,693 1,756
Total Operating Expenses		 939 911 929 938 923 898 809 963 920 937 989
Selling, General & Admin Expense		 508 220 474 461 452 438 455 465 428 446 472
Research & Development Expense		 431 434 455 477 471 460 478 498 492 491 517
Restructuring Charge		 - - - 0.00 0.00 - -124 0.00 0.00 - 0.00
Total Other Income / (Expense), net		 -20 -9.00 12 30 30 15 7.00 -1.00 0.00 -18 -48
Interest Expense		 53 60 68 89 98 98 116 131 131 130 128
Other Income / (Expense), net		 33 51 80 119 128 113 123 130 131 112 80
Income Tax Expense		 363 205 238 280 213 177 188 120 192 154 97
Preferred Stock Dividends Declared		 11 9.00 9.00 8.00 10 6.00 5.00 6.00 7.00 6.00 6.00
Basic Earnings per Share		 $2.50 $2.16 $1.87 $1.89 $1.87 $1.50 $1.21 $1.23 $1.48 $1.32 $1.29
Weighted Average Basic Shares Outstanding		 913M 916M 907M 908M 908M 908M 910M 912M 913M 912M 910M
Diluted Earnings per Share		 $2.47 $2.14 $1.85 $1.87 $1.85 $1.50 $1.20 $1.22 $1.47 $1.31 $1.28
Weighted Average Diluted Shares Outstanding		 923M 926M 916M 916M 916M 916M 917M 919M 920M 919M 916M
Weighted Average Basic & Diluted Shares Outstanding		 907.57M 906.21M 907.65M 907.97M 908.20M 909.29M 910.48M 913.05M 912.22M 910.33M 908.47M
Cash Dividends to Common per Share		 $1.15 - $1.24 $1.24 $1.24 - $1.30 $1.30 $1.30 - $1.36

Annual Cash Flow Statements for Texas Instruments

This table details how cash moves in and out of Texas Instruments' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 -199 154 502 782 -1.00 670 1,524 -1,581 -86 236
Net Cash From Operating Activities		 4,397 4,614 5,363 7,189 6,649 6,139 8,756 8,720 6,420 6,318
Net Cash From Continuing Operating Activities		 4,397 4,614 5,366 7,189 6,649 6,139 8,756 8,720 6,420 6,318
Net Income / (Loss) Continuing Operations		 2,986 3,595 3,682 5,580 5,017 5,595 7,769 8,749 6,510 4,799
Consolidated Net Income / (Loss)		 2,986 3,595 3,682 5,580 5,017 5,595 7,769 8,749 6,510 4,799
Depreciation Expense		 766 605 539 590 708 733 755 925 1,175 1,508
Amortization Expense		 367 350 365 364 342 259 199 54 63 72
Non-Cash Adjustments To Reconcile Net Income		 201 212 242 229 194 220 173 286 362 260
Changes in Operating Assets and Liabilities, net		 77 -148 538 426 388 -668 -140 -1,294 -1,690 -321
Net Cash From Investing Activities		 -302 -650 -1,127 -78 -1,920 -922 -4,095 -3,583 -4,362 -3,202
Net Cash From Continuing Investing Activities		 -302 -650 -1,127 -78 -1,920 -922 -4,095 -3,583 -4,362 -3,202
Purchase of Property, Plant & Equipment		 -551 -531 -695 -1,131 -847 -649 -2,462 -2,797 -5,071 -4,820
Purchase of Investments		 -2,767 -3,503 -4,555 -5,641 -3,444 -5,786 -10,124 -14,483 -12,705 -9,716
Sale of Property, Plant & Equipment		 110 0.00 40 9.00 30 4.00 75 3.00 3.00 195
Sale and/or Maturity of Investments		 2,892 3,390 4,095 6,708 2,309 5,545 8,478 13,657 13,387 11,187
Other Investing Activities, net		 14 -6.00 -12 -23 32 -36 -62 37 24 -48
Net Cash From Financing Activities		 -4,294 -3,810 -3,734 -6,329 -4,730 -4,547 -3,137 -6,718 -2,144 -2,880
Net Cash From Continuing Financing Activities		 -4,294 -3,810 -3,734 -6,329 -4,730 -4,547 -3,137 -6,718 -2,144 -2,880
Repayment of Debt		 -1,003 -1,003 -656 -547 -792 -536 -596 -541 -557 -653
Repurchase of Common Equity		 -2,741 -2,132 -2,556 -5,100 -2,960 -2,553 -527 -3,615 -293 -929
Payment of Dividends		 -1,444 -1,646 -2,104 -2,555 -3,008 -3,426 -3,886 -4,297 -4,557 -4,795
Issuance of Debt		 498 499 1,099 1,500 1,491 1,498 1,495 1,494 3,000 2,980
Issuance of Common Equity		 396 472 483 373 539 470 377 241 263 517

Quarterly Cash Flow Statements for Texas Instruments

This table details how cash moves in and out of Texas Instruments' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Change in Cash & Equivalents		 -633 -119 1,427 -1,038 -873 398 -481 257 -151 611 -437
Net Cash From Operating Activities		 2,766 2,042 1,160 1,399 1,937 1,924 1,017 1,571 1,732 1,998 849
Net Cash From Continuing Operating Activities		 2,766 2,042 1,160 1,399 1,937 1,924 1,017 1,571 1,732 1,998 849
Net Income / (Loss) Continuing Operations		 2,295 1,962 1,708 1,722 1,709 1,371 1,105 1,127 1,362 1,205 1,179
Consolidated Net Income / (Loss)		 2,295 1,962 1,708 1,722 1,709 1,371 1,105 1,127 1,362 1,205 1,179
Depreciation Expense		 249 249 265 285 303 322 346 363 383 416 424
Amortization Expense		 13 14 16 15 17 15 16 18 19 19 20
Non-Cash Adjustments To Reconcile Net Income		 68 62 104 110 79 69 -23 119 87 77 116
Changes in Operating Assets and Liabilities, net		 141 -245 -933 -733 -171 147 -427 -56 -119 281 -890
Net Cash From Investing Activities		 -2,113 -1,027 28 -2,385 -1,694 -311 -3,329 - -487 614 1,253
Net Cash From Continuing Investing Activities		 -2,113 -1,027 28 -2,385 -1,694 -311 -3,329 - -487 614 1,253
Purchase of Property, Plant & Equipment		 -790 -967 -982 -1,446 -1,495 -1,148 -1,248 -1,064 -1,316 -1,192 -1,123
Purchase of Investments		 -4,346 -3,688 -3,013 -4,047 -3,080 -2,565 -4,864 -2,098 -1,845 -909 -647
Sale of Property, Plant & Equipment		 - - 1.00 1.00 1.00 - 192 2.00 - 1.00 0.00
Sale and/or Maturity of Investments		 3,033 3,650 4,026 3,065 2,885 3,411 2,631 3,130 2,700 2,726 2,807
Other Investing Activities, net		 -10 -22 -4.00 42 -5.00 -9.00 -40 30 -26 -12 216
Net Cash From Financing Activities		 -1,286 -1,134 239 -52 -1,116 -1,215 1,831 -1,314 -1,396 -2,001 -2,539
Net Cash From Continuing Financing Activities		 -1,286 -1,134 239 -52 -1,116 -1,215 1,831 -1,314 -1,396 -2,001 -2,539
Repayment of Debt		 -12 -12 -15 -516 -12 -14 -28 -306 -8.00 -311 -766
Repurchase of Common Equity		 -996 -848 -103 -79 -46 -65 -3.00 -71 -318 -537 -653
Payment of Dividends		 -1,051 -1,123 -1,125 -1,125 -1,126 -1,181 -1,183 -1,185 -1,187 -1,240 -1,238
Issuance of Debt		 695 799 1,397 1,603 - - 2,980 - - - 0.00
Issuance of Common Equity		 78 50 85 65 68 45 65 248 117 87 118

Annual Balance Sheets for Texas Instruments

This table presents Texas Instruments' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 16,230 16,431 17,642 17,137 18,018 19,351 24,676 27,207 32,348 35,509
Total Current Assets		 7,074 7,457 8,734 8,097 8,761 10,239 13,685 14,021 15,122 15,026
Cash & Equivalents		 1,000 1,154 1,656 2,438 2,437 3,107 4,631 3,050 2,964 3,200
Short-Term Investments		 2,218 2,336 2,813 1,795 2,950 3,461 5,108 6,017 5,611 4,380
Accounts Receivable		 1,165 1,267 1,278 1,207 1,074 1,414 1,701 1,895 1,787 1,719
Inventories, net		 1,691 1,790 1,957 2,217 2,001 1,955 1,910 2,757 3,999 4,527
Prepaid Expenses		 1,000 910 1,030 440 299 302 335 302 761 1,200
Plant, Property, & Equipment, net		 2,596 2,512 2,664 3,183 3,303 3,269 5,141 6,876 9,999 11,347
Plant, Property & Equipment, gross		 5,465 4,923 4,789 5,425 5,740 5,781 7,858 9,950 13,268 15,254
Accumulated Depreciation		 2,869 2,411 2,125 2,242 2,437 2,512 2,717 3,074 3,269 3,907
Total Noncurrent Assets		 6,560 6,462 6,244 5,857 5,954 5,843 5,850 6,310 7,227 9,136
Goodwill		 4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362
Intangible Assets		 1,629 1,316 1,056 717 409 122 85 152 223 257
Noncurrent Deferred & Refundable Income Taxes		 201 374 264 295 197 343 263 473 757 936
Employee Benefit Assets		 85 96 208 92 218 246 392 188 173 233
Other Noncurrent Operating Assets		 62 79 86 140 468 770 748 1,135 1,712 3,348
Total Liabilities & Shareholders' Equity		 16,230 16,431 17,642 17,137 18,018 19,351 24,676 27,207 32,348 35,509
Total Liabilities		 6,284 5,958 7,305 8,143 9,111 10,164 11,343 12,630 15,451 18,606
Total Current Liabilities		 2,555 2,264 2,258 2,474 2,123 2,390 2,569 2,985 3,320 3,643
Short-Term Debt		 1,000 631 500 749 500 550 500 500 599 750
Accounts Payable		 386 396 466 478 388 415 571 851 802 820
Current Deferred & Payable Income Tax Liabilities		 95 83 128 103 46 134 121 189 172 159
Current Employee Benefit Liabilities		 664 710 722 724 714 767 775 799 836 839
Other Current Liabilities		 410 444 442 420 475 524 602 646 911 1,075
Total Noncurrent Liabilities		 3,729 3,694 5,047 5,669 6,988 7,774 8,774 9,645 12,131 14,963
Long-Term Debt		 3,120 2,978 3,577 4,319 5,303 6,248 7,241 8,235 10,624 12,846
Noncurrent Deferred & Payable Income Tax Liabilities		 37 33 78 42 78 90 87 66 63 53
Noncurrent Employee Benefit Liabilities		 196 129 89 118 93 131 79 118 108 110
Other Noncurrent Operating Liabilities		 - 554 1,303 1,190 1,514 1,305 1,367 1,226 1,336 1,954
Total Equity & Noncontrolling Interests		 9,946 10,473 10,337 8,994 8,907 9,187 13,333 14,577 16,897 16,903
Total Preferred & Common Equity		 9,946 10,473 10,337 8,994 8,907 9,187 13,333 14,577 16,897 16,903
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 9,946 10,473 10,337 8,994 8,907 9,187 13,333 14,577 16,897 16,903
Common Stock		 3,370 3,415 3,517 3,691 3,851 4,074 4,371 4,692 5,103 5,676
Retained Earnings		 31,176 33,107 34,662 37,906 39,898 42,051 45,919 50,353 52,283 52,262
Treasury Stock		 -24,068 -25,523 -27,458 -32,130 -34,495 -36,578 -36,800 -40,214 -40,284 -40,895
Accumulated Other Comprehensive Income / (Loss)		 -532 -526 -384 -473 -347 -360 -157 -254 -205 -140

Quarterly Balance Sheets for Texas Instruments

This table presents Texas Instruments' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Total Assets		 26,057 27,207 29,220 30,939 31,638 32,348 34,885 35,048 35,321 35,509 33,757
Total Current Assets		 13,772 14,021 15,023 15,514 15,097 15,122 17,448 16,789 15,872 15,026 13,086
Cash & Equivalents		 3,169 3,050 4,477 3,439 2,566 2,964 2,483 2,740 2,589 3,200 2,763
Short-Term Investments		 5,921 6,017 5,068 6,113 6,382 5,611 7,910 6,948 6,163 4,380 2,242
Accounts Receivable		 2,040 1,895 1,877 1,956 1,976 1,787 1,671 1,711 1,862 1,719 1,860
Inventories, net		 2,404 2,757 3,288 3,729 3,908 3,999 4,083 4,106 4,296 4,527 4,687
Prepaid Expenses		 238 302 313 277 265 761 1,301 1,284 962 1,200 1,534
Plant, Property, & Equipment, net		 6,485 6,876 7,665 8,525 9,320 9,999 10,442 11,174 11,802 11,347 11,811
Plant, Property & Equipment, gross		 9,491 9,950 10,791 11,664 12,528 13,268 13,739 14,622 15,464 15,254 16,036
Accumulated Depreciation		 3,006 3,074 3,126 3,139 3,208 3,269 3,297 3,448 3,662 3,907 4,225
Total Noncurrent Assets		 5,800 6,310 6,532 6,900 7,221 7,227 6,995 7,085 7,647 9,136 8,860
Goodwill		 4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362
Intangible Assets		 75 152 140 143 138 223 231 230 229 257 263
Noncurrent Deferred & Refundable Income Taxes		 291 473 486 537 632 757 821 905 941 936 1,030
Employee Benefit Assets		 273 188 189 183 166 173 169 167 184 233 240
Other Noncurrent Operating Assets		 799 1,135 1,355 1,675 1,923 1,712 1,412 1,421 1,931 3,348 2,965
Total Liabilities & Shareholders' Equity		 26,057 27,207 29,220 30,939 31,638 32,348 34,885 35,048 35,321 35,509 33,757
Total Liabilities		 11,550 12,630 13,977 14,999 15,007 15,451 17,902 17,834 18,053 18,606 17,351
Total Current Liabilities		 2,798 2,985 2,904 2,711 2,652 3,320 3,553 3,637 3,686 3,643 2,489
Short-Term Debt		 499 500 500 299 300 599 1,349 1,049 1,049 750 0.00
Accounts Payable		 780 851 952 923 713 802 551 858 794 820 866
Current Deferred & Payable Income Tax Liabilities		 123 189 372 121 108 172 378 178 108 159 284
Current Employee Benefit Liabilities		 662 799 394 561 707 836 399 569 721 839 418
Other Current Liabilities		 734 646 686 807 824 911 876 983 1,014 1,075 921
Total Noncurrent Liabilities		 8,752 9,645 11,073 12,288 12,355 12,131 14,349 14,197 14,367 14,963 14,862
Long-Term Debt		 7,438 8,235 9,626 10,920 10,922 10,624 12,840 12,842 12,844 12,846 12,848
Noncurrent Deferred & Payable Income Tax Liabilities		 92 66 73 69 66 63 55 55 54 53 56
Noncurrent Employee Benefit Liabilities		 69 118 123 127 141 108 111 113 117 110 115
Other Noncurrent Operating Liabilities		 1,153 1,226 1,251 1,172 1,226 1,336 1,343 1,187 1,352 1,954 1,843
Total Equity & Noncontrolling Interests		 14,507 14,577 15,243 15,940 16,631 16,897 16,983 17,214 17,268 16,903 16,406
Total Preferred & Common Equity		 14,507 14,577 15,243 15,940 16,631 16,897 16,983 17,214 17,268 16,903 16,406
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 14,507 14,577 15,243 15,940 16,631 16,897 16,983 17,214 17,268 16,903 16,406
Common Stock		 4,618 4,692 4,757 4,904 5,021 5,103 5,180 5,407 5,554 5,676 5,799
Retained Earnings		 49,519 50,353 50,930 51,522 52,098 52,283 52,199 52,135 52,304 52,262 52,196
Treasury Stock		 -39,476 -40,214 -40,192 -40,240 -40,253 -40,284 -40,193 -40,128 -40,395 -40,895 -41,442
Accumulated Other Comprehensive Income / (Loss)		 -154 -254 -252 -246 -235 -205 -203 -200 -195 -140 -147

Annual Metrics And Ratios for Texas Instruments

This table displays calculated financial ratios and metrics derived from Texas Instruments' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 -0.35% 2.85% 11.90% 5.50% -8.88% 0.54% 26.85% 9.18% -12.53% -10.72%
EBITDA Growth		 4.64% 9.67% 18.39% 9.95% -10.52% 3.61% 39.70% 11.61% -19.74% -16.29%
EBIT Growth		 8.52% 16.35% 22.91% 10.60% -13.40% 5.24% 46.66% 12.56% -24.16% -23.29%
NOPAT Growth		 6.50% 15.66% 4.05% 52.09% -10.53% 9.34% 42.41% 13.31% -27.25% -25.24%
Net Income Growth		 5.85% 20.40% 2.42% 51.55% -10.09% 11.52% 38.86% 12.61% -25.59% -26.28%
EPS Growth		 9.73% 23.40% 3.74% 54.85% -6.26% 13.93% 38.36% 13.92% -24.87% -26.45%
Operating Cash Flow Growth		 8.46% 4.94% 16.23% 34.05% -7.51% -7.67% 42.63% -0.41% -26.38% -1.59%
Free Cash Flow Firm Growth		 4.29% 3.26% 14.53% 30.65% -2.35% -8.64% 15.73% 0.79% -80.89% 26.63%
Invested Capital Growth		 -5.59% -2.54% -6.57% -1.02% -5.79% 4.37% 20.37% 25.67% 37.21% 17.26%
Revenue Q/Q Growth		 -0.61% 1.71% 2.30% -0.21% -2.49% 5.29% 4.30% -0.80% -3.27% -0.45%
EBITDA Q/Q Growth		 0.15% 5.69% 0.74% -0.09% -3.29% 10.19% 5.31% -2.05% -5.33% -0.78%
EBIT Q/Q Growth		 1.22% 7.63% 0.90% -0.47% -3.86% 12.16% 6.27% -2.71% -6.96% -2.57%
NOPAT Q/Q Growth		 1.24% 1.49% -13.48% 19.11% -3.60% 10.47% 8.09% -2.23% -8.68% -2.77%
Net Income Q/Q Growth		 0.37% 6.24% -16.03% 19.10% -3.26% 12.42% 6.15% -1.97% -8.32% -3.34%
EPS Q/Q Growth		 1.81% 6.75% -15.65% 19.44% -2.42% 12.64% 6.03% -1.36% -8.30% -3.53%
Operating Cash Flow Q/Q Growth		 2.93% -3.59% 11.24% 3.10% -5.55% 6.43% 2.72% -3.49% -1.80% 1.19%
Free Cash Flow Firm Q/Q Growth		 2.97% -7.35% 11.44% 5.96% -6.75% 5.42% -11.73% 2.31% -24.14% -0.48%
Invested Capital Q/Q Growth		 -4.70% -1.61% -10.97% -6.02% -4.22% -1.46% 12.14% 6.67% 3.39% 2.28%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 58.27% 61.76% 64.26% 65.11% 63.71% 64.10% 67.47% 68.76% 62.90% 58.14%
EBITDA Margin		 41.84% 44.61% 47.20% 49.20% 48.31% 49.78% 54.82% 56.05% 51.42% 48.21%
Operating Margin		 33.25% 36.31% 40.66% 42.53% 39.79% 40.76% 48.84% 50.63% 41.85% 34.94%
EBIT Margin		 33.12% 37.47% 41.16% 43.15% 41.01% 42.92% 49.62% 51.16% 44.36% 38.11%
Profit (Net Income) Margin		 22.97% 26.89% 24.61% 35.35% 34.88% 38.69% 42.35% 43.68% 37.16% 30.68%
Tax Burden Percent		 70.83% 72.92% 60.56% 83.46% 87.59% 92.99% 87.11% 87.21% 87.76% 88.01%
Interest Burden Percent		 97.91% 98.40% 98.73% 98.16% 97.12% 96.94% 97.98% 97.91% 95.46% 91.48%
Effective Tax Rate		 29.17% 27.08% 39.44% 16.54% 12.41% 7.01% 12.89% 12.79% 12.24% 11.99%
Return on Invested Capital (ROIC)		 27.98% 33.74% 36.78% 58.19% 53.90% 59.44% 75.22% 69.14% 38.08% 22.65%
ROIC Less NNEP Spread (ROIC-NNEP)		 18.27% 53.10% 37.24% 117.49% 55.15% 125.55% 79.26% 77.23% 44.67% 22.41%
Return on Net Nonoperating Assets (RNNOA)		 1.39% 1.47% -1.39% -0.46% 2.16% 2.40% -6.22% -6.45% 3.29% 5.74%
Return on Equity (ROE)		 29.37% 35.21% 35.39% 57.73% 56.05% 61.84% 69.00% 62.69% 41.37% 28.40%
Cash Return on Invested Capital (CROIC)		 33.73% 36.32% 43.56% 59.22% 59.86% 55.17% 56.73% 46.39% 6.71% 6.76%
Operating Return on Assets (OROA)		 25.63% 30.68% 36.15% 39.17% 33.55% 33.22% 41.35% 39.50% 26.10% 17.57%
Return on Assets (ROA)		 17.77% 22.01% 21.61% 32.09% 28.54% 29.94% 35.29% 33.73% 21.86% 14.14%
Return on Common Equity (ROCE)		 29.37% 35.21% 35.39% 57.73% 56.05% 61.84% 69.00% 62.69% 41.37% 28.40%
Return on Equity Simple (ROE_SIMPLE)		 30.02% 34.33% 35.62% 62.04% 56.33% 60.90% 58.27% 60.02% 38.53% 28.39%
Net Operating Profit after Tax (NOPAT)		 3,061 3,540 3,684 5,603 5,013 5,481 7,805 8,843 6,434 4,810
NOPAT Margin		 23.55% 26.48% 24.62% 35.50% 34.85% 37.90% 42.55% 44.15% 36.72% 30.75%
Net Nonoperating Expense Percent (NNEP)		 9.71% -19.36% -0.47% -59.30% -1.25% -66.11% -4.04% -8.08% -6.59% 0.24%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 37.93% 22.88% 15.77%
Cost of Revenue to Revenue		 41.73% 38.24% 35.74% 34.89% 36.29% 35.90% 32.53% 31.24% 37.10% 41.86%
SG&A Expenses to Revenue		 13.29% 13.03% 11.32% 10.67% 11.44% 11.39% 9.38% 8.51% 10.42% 11.47%
R&D to Revenue		 9.75% 10.14% 10.08% 9.88% 10.73% 10.58% 8.47% 8.34% 10.63% 12.52%
Operating Expenses to Revenue		 25.02% 25.45% 23.60% 22.58% 23.92% 23.34% 18.62% 18.13% 21.05% 23.20%
Earnings before Interest and Taxes (EBIT)		 4,306 5,010 6,158 6,811 5,898 6,207 9,103 10,246 7,771 5,961
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 5,439 5,965 7,062 7,765 6,948 7,199 10,057 11,225 9,009 7,541
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 4.41 5.64 8.27 8.60 11.79 14.79 12.05 9.63 8.84 10.05
Price to Tangible Book Value (P/TBV)		 11.09 12.32 17.38 19.75 25.40 28.88 18.08 13.94 12.14 13.82
Price to Revenue (P/Rev)		 3.37 4.42 5.71 4.90 7.30 9.39 8.76 7.01 8.53 10.86
Price to Earnings (P/E)		 14.90 16.63 23.42 13.96 21.07 24.40 20.76 16.11 23.07 35.56
Dividend Yield		 3.24% 2.77% 2.44% 3.27% 2.86% 2.51% 2.42% 3.03% 3.05% 2.83%
Earnings Yield		 6.71% 6.01% 4.27% 7.16% 4.75% 4.10% 4.82% 6.21% 4.33% 2.81%
Enterprise Value to Invested Capital (EV/IC)		 4.19 5.69 8.76 8.14 11.65 14.45 13.99 9.83 7.78 7.67
Enterprise Value to Revenue (EV/Rev)		 3.43 4.41 5.67 4.94 7.31 9.41 8.65 6.99 8.68 11.24
Enterprise Value to EBITDA (EV/EBITDA)		 8.19 9.88 12.01 10.03 15.13 18.90 15.77 12.47 16.88 23.31
Enterprise Value to EBIT (EV/EBIT)		 10.34 11.77 13.77 11.44 17.83 21.92 17.43 13.66 19.57 29.49
Enterprise Value to NOPAT (EV/NOPAT)		 14.55 16.65 23.02 13.91 20.98 24.83 20.32 15.83 23.64 36.55
Enterprise Value to Operating Cash Flow (EV/OCF)		 10.13 12.78 15.82 10.84 15.81 22.16 18.12 16.05 23.69 27.83
Enterprise Value to Free Cash Flow (EV/FCFF)		 12.07 15.47 19.44 13.67 18.89 26.75 26.95 23.59 134.14 122.47
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.41 0.34 0.39 0.56 0.65 0.74 0.58 0.60 0.66 0.80
Long-Term Debt to Equity		 0.31 0.28 0.35 0.48 0.60 0.68 0.54 0.56 0.63 0.76
Financial Leverage		 0.08 0.03 -0.04 0.00 0.04 0.02 -0.08 -0.08 0.07 0.26
Leverage Ratio		 1.65 1.60 1.64 1.80 1.96 2.07 1.96 1.86 1.89 2.01
Compound Leverage Factor		 1.62 1.57 1.62 1.77 1.91 2.00 1.92 1.82 1.81 1.84
Debt to Total Capital		 29.29% 25.63% 28.29% 36.04% 39.45% 42.53% 36.73% 37.47% 39.91% 44.58%
Short-Term Debt to Total Capital		 7.11% 4.48% 3.47% 5.33% 3.40% 3.44% 2.37% 2.14% 2.13% 2.46%
Long-Term Debt to Total Capital		 22.18% 21.15% 24.82% 30.71% 36.05% 39.09% 34.36% 35.33% 37.78% 42.12%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 70.71% 74.37% 71.72% 63.96% 60.55% 57.47% 63.27% 62.53% 60.09% 55.42%
Debt to EBITDA		 0.76 0.61 0.58 0.65 0.84 0.94 0.77 0.78 1.25 1.80
Net Debt to EBITDA		 0.13 -0.02 -0.09 0.08 0.02 0.03 -0.20 -0.03 0.29 0.80
Long-Term Debt to EBITDA		 0.57 0.50 0.51 0.56 0.76 0.87 0.72 0.73 1.18 1.70
Debt to NOPAT		 1.35 1.02 1.11 0.90 1.16 1.24 0.99 0.99 1.74 2.83
Net Debt to NOPAT		 0.22 -0.03 -0.18 0.10 0.02 0.04 -0.26 -0.04 0.41 1.25
Long-Term Debt to NOPAT		 1.02 0.84 0.97 0.77 1.06 1.14 0.93 0.93 1.65 2.67
Altman Z-Score		 8.89 10.97 12.21 11.42 12.34 13.35 13.60 11.72 9.84 8.92
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 2.77 3.29 3.87 3.27 4.13 4.28 5.33 4.70 4.55 4.12
Quick Ratio		 1.72 2.10 2.55 2.20 3.04 3.34 4.45 3.67 3.12 2.55
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 3,690 3,810 4,364 5,702 5,568 5,087 5,887 5,933 1,134 1,436
Operating Cash Flow to CapEx		 997.05% 868.93% 818.78% 640.73% 813.83% 951.78% 366.82% 312.10% 126.68% 136.61%
Free Cash Flow to Firm to Interest Expense		 41.00 47.63 55.95 45.61 32.75 26.77 31.99 27.73 3.21 2.83
Operating Cash Flow to Interest Expense		 48.86 57.68 68.76 57.51 39.11 32.31 47.59 40.75 18.19 12.44
Operating Cash Flow Less CapEx to Interest Expense		 43.96 51.04 60.36 48.54 34.31 28.92 34.61 27.69 3.83 3.33
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.77 0.82 0.88 0.91 0.82 0.77 0.83 0.77 0.59 0.46
Accounts Receivable Turnover		 10.78 11.00 11.76 12.70 12.61 11.62 11.78 11.14 9.52 8.92
Inventory Turnover		 3.12 2.94 2.85 2.64 2.47 2.62 3.09 2.68 1.92 1.54
Fixed Asset Turnover		 4.78 5.23 5.78 5.40 4.44 4.40 4.36 3.33 2.08 1.47
Accounts Payable Turnover		 13.18 13.08 12.41 11.67 12.05 12.93 12.11 8.80 7.86 8.07
Days Sales Outstanding (DSO)		 33.85 33.20 31.04 28.73 28.94 31.40 30.99 32.77 38.36 40.91
Days Inventory Outstanding (DIO)		 116.90 124.25 127.89 138.32 147.50 139.05 118.19 136.12 189.69 237.67
Days Payable Outstanding (DPO)		 27.69 27.91 29.42 31.28 30.28 28.23 30.15 41.48 46.41 45.21
Cash Conversion Cycle (CCC)		 123.06 129.53 129.51 135.77 146.16 142.23 119.03 127.42 181.63 233.36
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 10,627 10,357 9,677 9,578 9,023 9,417 11,335 14,245 19,545 22,919
Invested Capital Turnover		 1.19 1.27 1.49 1.64 1.55 1.57 1.77 1.57 1.04 0.74
Increase / (Decrease) in Invested Capital		 -629 -270 -680 -99 -555 394 1,918 2,910 5,300 3,374
Enterprise Value (EV)		 44,534 58,954 84,816 77,917 105,150 136,070 158,627 139,990 152,067 175,810
Market Capitalization		 43,853 59,070 85,476 77,333 105,034 135,840 160,625 140,322 149,419 169,794
Book Value per Share		 $9.80 $10.48 $10.49 $9.36 $9.53 $10.01 $14.44 $16.06 $18.60 $18.53
Tangible Book Value per Share		 $3.90 $4.80 $4.99 $4.08 $4.42 $5.12 $9.62 $11.09 $13.56 $13.47
Total Capital		 14,066 14,082 14,414 14,062 14,710 15,985 21,074 23,312 28,120 30,499
Total Debt		 4,120 3,609 4,077 5,068 5,803 6,798 7,741 8,735 11,223 13,596
Total Long-Term Debt		 3,120 2,978 3,577 4,319 5,303 6,248 7,241 8,235 10,624 12,846
Net Debt		 681 -116 -660 584 116 230 -1,998 -332 2,648 6,016
Capital Expenditures (CapEx)		 441 531 655 1,122 817 645 2,387 2,794 5,068 4,625
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 2,301 2,334 2,507 2,139 1,751 1,831 1,877 2,469 3,826 4,553
Debt-free Net Working Capital (DFNWC)		 5,519 5,824 6,976 6,372 7,138 8,399 11,616 11,536 12,401 12,133
Net Working Capital (NWC)		 4,519 5,193 6,476 5,623 6,638 7,849 11,116 11,036 11,802 11,383
Net Nonoperating Expense (NNE)		 75 -55 1.82 23 -4.38 -114 36 94 -76 11
Net Nonoperating Obligations (NNO)		 681 -116 -660 584 116 230 -1,998 -332 2,648 6,016
Total Depreciation and Amortization (D&A)		 1,133 955 904 954 1,050 992 954 979 1,238 1,580
Debt-free, Cash-free Net Working Capital to Revenue		 17.70% 17.46% 16.76% 13.55% 12.17% 12.66% 10.23% 12.33% 21.84% 29.11%
Debt-free Net Working Capital to Revenue		 42.45% 43.56% 46.63% 40.37% 49.63% 58.08% 63.32% 57.60% 70.79% 77.57%
Net Working Capital to Revenue		 34.76% 38.84% 43.29% 35.62% 46.15% 54.28% 60.60% 55.10% 67.37% 72.78%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $5.33 $6.05 $8.38 $9.51 $7.13 $5.24
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 0.00 0.00 936M 921M 923M 916M 908M 912M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $5.24 $5.97 $8.26 $9.41 $7.07 $5.20
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 0.00 0.00 952M 933M 936M 926M 916M 919M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 0.00 0.00 933.98M 920.24M 923.55M 906.21M 909.29M 910.33M
Normalized Net Operating Profit after Tax (NOPAT)		 3,244 3,762 3,883 5,870 4,981 5,481 7,805 9,067 6,434 4,700
Normalized NOPAT Margin		 24.95% 28.14% 25.95% 37.19% 34.63% 37.90% 42.55% 45.27% 36.72% 30.05%
Pre Tax Income Margin		 32.43% 36.87% 40.64% 42.36% 39.82% 41.61% 48.62% 50.09% 42.34% 34.86%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 47.84 62.63 78.95 54.49 34.69 32.67 49.47 47.88 22.01 11.73
NOPAT to Interest Expense		 34.01 44.25 47.23 44.82 29.49 28.85 42.42 41.32 18.23 9.47
EBIT Less CapEx to Interest Expense		 42.94 55.99 70.55 45.51 29.89 29.27 36.50 34.82 7.66 2.63
NOPAT Less CapEx to Interest Expense		 29.11 37.62 38.83 35.84 24.68 25.45 29.44 28.27 3.87 0.36
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 48.36% 45.79% 57.14% 45.79% 59.96% 61.23% 50.02% 49.11% 70.00% 99.92%
Augmented Payout Ratio		 140.15% 105.09% 126.56% 137.19% 118.96% 106.86% 56.80% 90.43% 74.50% 119.27%

Quarterly Metrics And Ratios for Texas Instruments

This table displays calculated financial ratios and metrics derived from Texas Instruments' official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 12.88% -3.35% -10.72% -13.07% -13.53% -12.70% -16.40% -15.65% -8.41% -1.72% 11.14%
EBITDA Growth		 15.55% -8.62% -17.80% -19.49% -21.29% -20.36% -22.83% -26.43% -10.81% -2.98% 4.35%
EBIT Growth		 16.85% -11.35% -21.88% -23.41% -25.49% -26.09% -30.04% -34.10% -16.58% -9.54% -0.35%
NOPAT Growth		 17.21% -9.32% -23.99% -27.10% -27.24% -31.09% -35.26% -33.50% -19.04% -10.07% 11.31%
Net Income Growth		 17.87% -8.23% -22.40% -24.84% -25.53% -30.12% -35.30% -34.55% -20.30% -12.11% 6.70%
EPS Growth		 19.32% -5.73% -21.28% -23.67% -25.10% -29.91% -35.14% -34.76% -20.54% -12.67% 6.67%
Operating Cash Flow Growth		 13.92% -13.36% -45.90% -20.87% -29.97% -5.78% -12.33% 12.29% -10.58% 3.85% -16.52%
Free Cash Flow Firm Growth		 -165.68% -468.97% -7,598.53% -387.05% -314.32% -319.46% -75.87% 9.44% 44.63% 45.39% 41.74%
Invested Capital Growth		 32.11% 25.67% 32.60% 35.97% 41.57% 37.21% 31.31% 21.64% 18.53% 17.26% 16.70%
Revenue Q/Q Growth		 0.56% -10.89% -6.23% 3.47% 0.02% -10.04% -10.20% 4.40% 8.61% -3.47% 1.55%
EBITDA Q/Q Growth		 0.10% -16.25% -7.83% 4.18% -2.13% -15.26% -10.69% -0.68% 18.65% -7.81% -3.95%
EBIT Q/Q Growth		 -0.70% -17.85% -9.56% 3.82% -3.40% -18.51% -14.40% -2.20% 22.28% -11.63% -5.71%
NOPAT Q/Q Growth		 -0.63% -14.80% -13.84% -0.07% -0.82% -19.30% -19.05% 2.63% 20.76% -10.36% 0.20%
Net Income Q/Q Growth		 0.17% -14.51% -12.95% 0.82% -0.75% -19.78% -19.40% 1.99% 20.85% -11.53% -2.16%
EPS Q/Q Growth		 0.82% -13.36% -13.55% 1.08% -1.07% -18.92% -20.00% 1.67% 20.49% -10.88% -2.29%
Operating Cash Flow Q/Q Growth		 56.45% -26.18% -43.19% 20.60% 38.46% -0.67% -47.14% 54.47% 10.25% 15.36% -57.51%
Free Cash Flow Firm Q/Q Growth		 -53.55% -0.66% -133.29% -35.09% -30.62% -1.90% 2.19% 30.44% 20.14% -0.52% -4.35%
Invested Capital Q/Q Growth		 3.13% 6.67% 11.08% 11.27% 7.37% 3.39% 6.31% 3.07% 4.63% 2.28% 5.80%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 69.01% 66.10% 65.38% 64.22% 62.11% 59.63% 57.22% 57.85% 59.60% 57.75% 56.84%
EBITDA Margin		 56.73% 53.32% 52.41% 52.77% 51.63% 48.64% 48.37% 46.02% 50.28% 48.02% 45.42%
Operating Margin		 51.10% 46.60% 44.17% 43.52% 41.75% 37.60% 35.13% 32.65% 37.44% 34.36% 32.54%
EBIT Margin		 51.73% 47.69% 45.99% 46.15% 44.57% 40.37% 38.49% 36.05% 40.59% 37.16% 34.50%
Profit (Net Income) Margin		 43.79% 42.01% 39.00% 38.00% 37.71% 33.63% 30.18% 29.49% 32.81% 30.07% 28.98%
Tax Burden Percent		 86.34% 90.54% 87.77% 86.01% 88.92% 88.57% 85.46% 90.38% 87.64% 88.67% 92.40%
Interest Burden Percent		 98.05% 97.31% 96.62% 95.74% 95.15% 94.05% 91.77% 90.49% 92.23% 91.27% 90.88%
Effective Tax Rate		 13.66% 9.46% 12.23% 13.99% 11.08% 11.43% 14.54% 9.62% 12.36% 11.33% 7.60%
Return on Invested Capital (ROIC)		 75.93% 66.06% 54.47% 46.12% 41.68% 34.53% 27.56% 24.34% 24.96% 22.45% 21.43%
ROIC Less NNEP Spread (ROIC-NNEP)		 77.01% 66.76% 53.07% 55.97% 46.44% 35.68% 27.83% 24.31% 24.96% 22.08% 20.67%
Return on Net Nonoperating Assets (RNNOA)		 -9.23% -5.57% -2.72% 0.98% 1.67% 2.63% 3.78% 4.30% 5.46% 5.66% 7.21%
Return on Equity (ROE)		 66.70% 60.49% 51.74% 47.09% 43.36% 37.16% 31.34% 28.64% 30.41% 28.11% 28.64%
Cash Return on Invested Capital (CROIC)		 49.43% 46.39% 31.83% 19.75% 9.26% 6.71% 4.81% 7.47% 6.98% 6.76% 6.50%
Operating Return on Assets (OROA)		 42.34% 36.82% 32.92% 31.21% 27.98% 23.75% 20.17% 17.58% 19.05% 17.13% 16.13%
Return on Assets (ROA)		 35.84% 32.44% 27.92% 25.70% 23.68% 19.78% 15.82% 14.38% 15.40% 13.86% 13.55%
Return on Common Equity (ROCE)		 66.70% 60.49% 51.74% 47.09% 43.36% 37.16% 31.34% 28.64% 30.41% 28.11% 28.64%
Return on Equity Simple (ROE_SIMPLE)		 61.52% 0.00% 54.16% 48.22% 42.70% 0.00% 34.78% 30.86% 28.75% 0.00% 29.70%
Net Operating Profit after Tax (NOPAT)		 2,312 1,970 1,697 1,696 1,682 1,358 1,099 1,128 1,362 1,221 1,223
NOPAT Margin		 44.12% 42.19% 38.76% 37.44% 37.12% 33.30% 30.02% 29.51% 32.81% 30.47% 30.07%
Net Nonoperating Expense Percent (NNEP)		 -1.08% -0.70% 1.40% -9.85% -4.76% -1.15% -0.27% 0.03% 0.00% 0.37% 0.76%
Return On Investment Capital (ROIC_SIMPLE)		 - 8.45% - - - 4.83% - - - 4.00% 4.18%
Cost of Revenue to Revenue		 30.99% 33.90% 34.62% 35.78% 37.89% 40.37% 42.78% 42.15% 40.40% 42.25% 43.16%
SG&A Expenses to Revenue		 9.69% 4.71% 10.82% 10.17% 9.97% 10.74% 12.43% 12.17% 10.31% 11.13% 11.60%
R&D to Revenue		 8.22% 9.29% 10.39% 10.53% 10.39% 11.28% 13.06% 13.03% 11.85% 12.25% 12.71%
Operating Expenses to Revenue		 17.92% 19.51% 21.21% 20.70% 20.37% 22.03% 22.10% 25.20% 22.16% 23.38% 24.31%
Earnings before Interest and Taxes (EBIT)		 2,711 2,227 2,014 2,091 2,020 1,646 1,409 1,378 1,685 1,489 1,404
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 2,973 2,490 2,295 2,391 2,340 1,983 1,771 1,759 2,087 1,924 1,848
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 9.18 9.63 10.57 9.87 8.42 8.84 9.19 10.22 10.92 10.05 9.97
Price to Tangible Book Value (P/TBV)		 13.22 13.94 15.00 13.76 11.54 12.14 12.60 13.94 14.88 13.82 13.89
Price to Revenue (P/Rev)		 6.59 7.01 8.26 8.36 7.73 8.53 9.29 10.94 12.00 10.86 10.19
Price to Earnings (P/E)		 14.98 16.11 19.60 20.57 19.82 23.07 26.55 33.30 38.17 35.56 33.74
Dividend Yield		 3.16% 3.03% 2.69% 2.81% 3.22% 3.05% 2.96% 2.66% 2.52% 2.83% 2.96%
Earnings Yield		 6.67% 6.21% 5.10% 4.86% 5.05% 4.33% 3.77% 3.00% 2.62% 2.81% 2.96%
Enterprise Value to Invested Capital (EV/IC)		 9.88 9.83 10.22 9.03 7.53 7.78 7.69 8.41 8.65 7.67 7.07
Enterprise Value to Revenue (EV/Rev)		 6.54 6.99 8.29 8.45 7.86 8.68 9.52 11.20 12.33 11.24 10.68
Enterprise Value to EBITDA (EV/EBITDA)		 11.52 12.47 15.07 15.67 14.95 16.88 18.84 22.94 25.49 23.31 22.50
Enterprise Value to EBIT (EV/EBIT)		 12.53 13.66 16.70 17.59 17.04 19.57 22.31 27.92 31.67 29.49 28.78
Enterprise Value to NOPAT (EV/NOPAT)		 14.59 15.83 19.46 20.72 20.20 23.64 27.40 34.21 39.17 36.55 34.75
Enterprise Value to Operating Cash Flow (EV/OCF)		 14.61 16.05 20.90 21.59 21.76 23.69 25.47 27.94 31.03 27.83 27.87
Enterprise Value to Free Cash Flow (EV/FCFF)		 22.76 23.59 36.60 52.70 95.22 134.14 181.58 123.67 134.31 122.47 117.17
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.55 0.60 0.66 0.70 0.67 0.66 0.84 0.81 0.80 0.80 0.78
Long-Term Debt to Equity		 0.51 0.56 0.63 0.69 0.66 0.63 0.76 0.75 0.74 0.76 0.78
Financial Leverage		 -0.12 -0.08 -0.05 0.02 0.04 0.07 0.14 0.18 0.22 0.26 0.35
Leverage Ratio		 1.85 1.86 1.86 1.85 1.85 1.89 1.99 1.99 1.98 2.01 2.06
Compound Leverage Factor		 1.81 1.81 1.80 1.77 1.76 1.78 1.83 1.80 1.82 1.83 1.87
Debt to Total Capital		 35.36% 37.47% 39.91% 41.31% 40.29% 39.91% 45.52% 44.66% 44.58% 44.58% 43.92%
Short-Term Debt to Total Capital		 2.22% 2.14% 1.97% 1.10% 1.08% 2.13% 4.33% 3.37% 3.37% 2.46% 0.00%
Long-Term Debt to Total Capital		 33.14% 35.33% 37.94% 40.21% 39.21% 37.78% 41.19% 41.29% 41.22% 42.12% 43.92%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 64.64% 62.53% 60.09% 58.69% 59.71% 60.09% 54.48% 55.34% 55.42% 55.42% 56.08%
Debt to EBITDA		 0.69 0.78 0.94 1.11 1.18 1.25 1.67 1.77 1.83 1.80 1.69
Net Debt to EBITDA		 -0.10 -0.03 0.05 0.16 0.24 0.29 0.45 0.54 0.68 0.80 1.03
Long-Term Debt to EBITDA		 0.65 0.73 0.90 1.08 1.15 1.18 1.51 1.64 1.69 1.70 1.69
Debt to NOPAT		 0.88 0.99 1.22 1.46 1.59 1.74 2.43 2.64 2.81 2.83 2.60
Net Debt to NOPAT		 -0.13 -0.04 0.07 0.22 0.32 0.41 0.65 0.80 1.04 1.25 1.59
Long-Term Debt to NOPAT		 0.82 0.93 1.16 1.42 1.55 1.65 2.20 2.44 2.60 2.67 2.60
Altman Z-Score		 11.20 10.75 10.75 9.95 9.16 9.21 8.42 9.04 9.36 8.50 8.81
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 4.92 4.70 5.17 5.72 5.69 4.55 4.91 4.62 4.31 4.12 5.26
Quick Ratio		 3.98 3.67 3.93 4.24 4.12 3.12 3.40 3.13 2.88 2.55 2.76
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -934 -940 -2,193 -2,962 -3,869 -3,942 -3,856 -2,682 -2,142 -2,153 -2,247
Operating Cash Flow to CapEx		 350.13% 211.17% 118.25% 96.82% 129.65% 167.60% 96.31% 147.93% 131.61% 167.76% 75.60%
Free Cash Flow to Firm to Interest Expense		 -17.62 -15.66 -32.24 -33.28 -39.48 -40.23 -33.24 -20.47 -16.35 -16.56 -17.55
Operating Cash Flow to Interest Expense		 52.19 34.03 17.06 15.72 19.77 19.63 8.77 11.99 13.22 15.37 6.63
Operating Cash Flow Less CapEx to Interest Expense		 37.28 17.92 2.63 -0.52 4.52 7.92 -0.34 3.89 3.18 6.21 -2.14
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.82 0.77 0.72 0.68 0.63 0.59 0.52 0.49 0.47 0.46 0.47
Accounts Receivable Turnover		 10.93 11.14 10.62 9.08 9.02 9.52 9.47 8.78 8.19 8.92 9.09
Inventory Turnover		 2.89 2.68 2.36 2.14 2.04 1.92 1.78 1.67 1.58 1.54 1.54
Fixed Asset Turnover		 3.84 3.33 2.98 2.60 2.29 2.08 1.86 1.63 1.49 1.47 1.44
Accounts Payable Turnover		 8.95 8.80 7.92 7.76 8.62 7.86 8.72 7.34 8.63 8.07 9.51
Days Sales Outstanding (DSO)		 33.38 32.77 34.36 40.20 40.47 38.36 38.54 41.59 44.58 40.91 40.15
Days Inventory Outstanding (DIO)		 126.50 136.12 154.68 170.53 178.96 189.69 205.38 218.64 230.34 237.67 237.57
Days Payable Outstanding (DPO)		 40.79 41.48 46.07 47.03 42.33 46.41 41.88 49.70 42.31 45.21 38.39
Cash Conversion Cycle (CCC)		 119.09 127.42 142.97 163.70 177.09 181.63 202.04 210.53 232.61 233.36 239.34
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 13,354 14,245 15,824 17,607 18,905 19,545 20,779 21,417 22,409 22,919 24,249
Invested Capital Turnover		 1.72 1.57 1.41 1.23 1.12 1.04 0.92 0.82 0.76 0.74 0.71
Increase / (Decrease) in Invested Capital		 3,246 2,910 3,890 4,658 5,551 5,300 4,955 3,810 3,504 3,374 3,470
Enterprise Value (EV)		 131,986 139,990 161,674 159,024 142,291 152,067 159,866 180,174 193,749 175,810 171,430
Market Capitalization		 133,139 140,322 161,093 157,357 140,017 149,419 156,070 175,971 188,608 169,794 163,587
Book Value per Share		 $15.88 $16.06 $16.82 $17.56 $18.32 $18.60 $18.66 $18.91 $18.91 $18.53 $18.02
Tangible Book Value per Share		 $11.02 $11.09 $11.85 $12.60 $13.36 $13.56 $13.62 $13.86 $13.88 $13.47 $12.94
Total Capital		 22,444 23,312 25,369 27,159 27,853 28,120 31,172 31,105 31,161 30,499 29,254
Total Debt		 7,937 8,735 10,126 11,219 11,222 11,223 14,189 13,891 13,893 13,596 12,848
Total Long-Term Debt		 7,438 8,235 9,626 10,920 10,922 10,624 12,840 12,842 12,844 12,846 12,848
Net Debt		 -1,153 -332 581 1,667 2,274 2,648 3,796 4,203 5,141 6,016 7,843
Capital Expenditures (CapEx)		 790 967 981 1,445 1,494 1,148 1,056 1,062 1,316 1,191 1,123
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 2,383 2,469 3,074 3,550 3,797 3,826 4,851 4,513 4,483 4,553 5,592
Debt-free Net Working Capital (DFNWC)		 11,473 11,536 12,619 13,102 12,745 12,401 15,244 14,201 13,235 12,133 10,597
Net Working Capital (NWC)		 10,974 11,036 12,119 12,803 12,445 11,802 13,895 13,152 12,186 11,383 10,597
Net Nonoperating Expense (NNE)		 17 8.15 -11 -26 -27 -13 -5.98 0.90 0.00 16 44
Net Nonoperating Obligations (NNO)		 -1,153 -332 581 1,667 2,274 2,648 3,796 4,203 5,141 6,016 7,843
Total Depreciation and Amortization (D&A)		 262 263 281 300 320 337 362 381 402 435 444
Debt-free, Cash-free Net Working Capital to Revenue		 11.80% 12.33% 15.76% 18.86% 20.96% 21.84% 28.87% 28.05% 28.53% 29.11% 34.84%
Debt-free Net Working Capital to Revenue		 56.83% 57.60% 64.71% 69.61% 70.37% 70.79% 90.73% 88.25% 84.24% 77.57% 66.03%
Net Working Capital to Revenue		 54.35% 55.10% 62.14% 68.03% 68.71% 67.37% 82.70% 81.73% 77.56% 72.78% 66.03%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $2.50 $2.16 $1.87 $1.89 $1.87 $1.50 $1.21 $1.23 $1.48 $1.32 $1.29
Adjusted Weighted Average Basic Shares Outstanding		 913M 916M 907M 908M 908M 908M 910M 912M 913M 912M 910M
Adjusted Diluted Earnings per Share		 $2.47 $2.14 $1.85 $1.87 $1.85 $1.50 $1.20 $1.22 $1.47 $1.31 $1.28
Adjusted Weighted Average Diluted Shares Outstanding		 923M 926M 916M 916M 916M 916M 917M 919M 920M 919M 916M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 907.57M 906.21M 907.65M 907.97M 908.20M 909.29M 910.48M 913.05M 912.22M 910.33M 908.47M
Normalized Net Operating Profit after Tax (NOPAT)		 2,312 1,970 1,697 1,696 1,682 1,358 993 1,128 1,362 1,221 1,223
Normalized NOPAT Margin		 44.12% 42.19% 38.76% 37.44% 37.12% 33.30% 27.13% 29.51% 32.81% 30.47% 30.07%
Pre Tax Income Margin		 50.72% 46.40% 44.44% 44.18% 42.41% 37.97% 35.32% 32.63% 37.44% 33.92% 31.36%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 51.15 37.12 29.62 23.49 20.61 16.80 12.15 10.52 12.86 11.45 10.97
NOPAT to Interest Expense		 43.63 32.84 24.96 19.06 17.17 13.85 9.47 8.61 10.40 9.39 9.56
EBIT Less CapEx to Interest Expense		 36.25 21.00 15.19 7.26 5.37 5.08 3.04 2.41 2.82 2.29 2.20
NOPAT Less CapEx to Interest Expense		 28.72 16.72 10.54 2.82 1.92 2.14 0.37 0.50 0.35 0.23 0.78
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 47.46% 49.11% 52.80% 57.55% 63.36% 70.00% 78.13% 88.01% 95.39% 99.92% 99.53%
Augmented Payout Ratio		 80.06% 90.43% 90.70% 83.91% 78.51% 74.50% 81.40% 91.49% 104.59% 119.27% 131.93%

Key Financial Trends

Texas Instruments (NASDAQ: TXN) demonstrated solid financial performance over the last four years, including recent Q1 2025 results. The company has seen fluctuating revenues and expenses but has maintained consistent profitability and operational cash flow generation. Below are the key financial trends and notable points from the income statement, cash flow statement, and balance sheet spanning from Q3 2022 through Q1 2025.

  • Consistent Revenue Growth: Revenues have generally stayed robust, with Q1 2025 total revenue at $4.07 billion, slightly up from $4.01 billion in Q4 2024 and higher than prior quarters in 2024 and 2023. This indicates stable demand for Texas Instruments' products.
  • Healthy Gross Margins: Gross profit remains strong, with Q1 2025 gross profit at $2.31 billion, maintaining a stable margin percentage considering revenues around $4 billion. This reflects efficient cost management in production.
  • Strong Net Income and Earnings Per Share (EPS): Net income for Q1 2025 was $1.17 billion, with diluted EPS of $1.28, consistent with recent quarters. Earnings have been stable above $1 billion per quarter, supporting shareholder returns.
  • Robust Operating Cash Flow: Q1 2025 operating cash flow was $849 million, indicating the business continues to generate strong cash from operations despite capital expenditures.
  • Capital Investments Supporting Growth: Texas Instruments has invested heavily in property, plant, and equipment over the quarters, with purchases exceeding $1 billion in Q1 2025, aiming to expand production capacity.
  • Strong Balance Sheet: The company holds cash and equivalents totaling approximately $2.76 billion and short-term investments of $2.24 billion at Q1 2025, providing ample liquidity.
  • Equity and Shareholder Returns: Total common equity stood at $16.4 billion in Q1 2025, with steady dividends of around $1.30 to $1.36 per share quarterly, highlighting a commitment to shareholder returns.
  • Debt Levels Remain Substantial: Long-term debt has increased to approximately $12.8 billion in Q1 2025 from about $9.6 billion in early 2023. While manageable given cash flow, rising debt warrants monitoring.
  • Inventory Levels Rising: Inventory increased to $4.69 billion in Q1 2025 from lower levels in prior quarters, which might reflect build-up in anticipation of demand or supply chain factors.
  • Growing Financing Cash Flow Outflows: In Q1 2025, cash used in financing activities increased to nearly $2.54 billion, mainly due to dividends paid, debt repayment, and share repurchases, which could limit financial flexibility if sustained at high levels.

Summary: Texas Instruments continues to display robust financial health with consistent revenue and profit generation, strong operating cash flows, and ongoing capital investments. The company supports shareholders through dividends and buybacks supported by a strong equity base. However, increased debt and high financing outflows imply the need for prudent financial management going forward. Investors should watch for future revenue trends and how the company manages its capital expenditures and debt load.

08/03/25 03:32 AMAI Generated. May Contain Errors.

Frequently Asked Questions About Texas Instruments' Financials

When does Texas Instruments' fiscal year end?

According to the most recent income statement we have on file, Texas Instruments' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Texas Instruments' net income changed over the last 9 years?

Texas Instruments' net income appears to be on an upward trend, with a most recent value of $4.80 billion in 2024, rising from $2.99 billion in 2015. The previous period was $6.51 billion in 2023. See Texas Instruments' forecast for analyst expectations on what’s next for the company.

What is Texas Instruments' operating income?
Texas Instruments' total operating income in 2024 was $5.47 billion, based on the following breakdown:
  • Total Gross Profit: $9.09 billion
  • Total Operating Expenses: $3.63 billion
How has Texas Instruments' revenue changed over the last 9 years?

Over the last 9 years, Texas Instruments' total revenue changed from $13 billion in 2015 to $15.64 billion in 2024, a change of 20.3%.

How much debt does Texas Instruments have?

Texas Instruments' total liabilities were at $18.61 billion at the end of 2024, a 20.4% increase from 2023, and a 196.1% increase since 2015.

How much cash does Texas Instruments have?

In the past 9 years, Texas Instruments' cash and equivalents has ranged from $1 billion in 2015 to $4.63 billion in 2021, and is currently $3.20 billion as of their latest financial filing in 2024.

How has Texas Instruments' book value per share changed over the last 9 years?

Over the last 9 years, Texas Instruments' book value per share changed from 9.80 in 2015 to 18.53 in 2024, a change of 89.0%.


Related Companies

This page (NASDAQ:TXN) was last updated on 8/3/2025 by MarketBeat.com Staff
From Our Partners
Man Who Called Nvidia at $1.10 Says Buy This Now...
In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...
The Oxford Club | Sponsored
Crypto Income (almost instantly)
How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...
Awesomely, LLC | Sponsored
Ex-Hedge Fund Manager Uncovers $100 Trillion Land Shift
Trump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...
Stansberry Research | Sponsored
Investigating the Most Controversial Stock on Earth
Tesla’s wild price swings may not be random after all. Hedge fund veteran Larry Benedict has uncovered a st...
Brownstone Research | Sponsored
This New Rule Could Change Everything
A major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...
American Alternative | Sponsored
Sell these "safe" blue chips immediately
Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...
InvestorPlace | Sponsored
Too busy to trade? Good.
Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...
Timothy Sykes | Sponsored
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond
Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...
Weiss Ratings | Sponsored